The lower prices stem from the Medicare negotiation program created under the Biden administration’s Inflation Reduction Act.
The Centers for Medicare and Medicaid Services on Tuesday announced lower prices on 15 costly prescription drugs under Medicare, including Ozempic and Wegovy.
The price cuts come through the Medicare drug price negotiation program created under the Inflation Reduction Act, which Joe Biden signed into law in 2022.
It’s different from Donald Trump’s “most favored nation” drug pricing approach, which relies on executive orders and voluntary deals with drugmakers — not legislation. Trump recently announced such a deal with Novo Nordisk, the maker of Ozempic and Wegovy, to lower the price of the drugs in exchange for tariff relief.
For some, it’s not a poor eating habits, it’s that they have other issues that prevent weight loss.
Look at Oprah, one of the wealthiest women in the world. Undoubtedly has had chefs cooking for her for decades; wasn’t able to fully manage her weight until glp-1 drugs.
I get that might not be who people see using these drugs, but the people who really need these medications are those who have issues preventing them from losing the weight.